Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen

NCT01929759 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

HIV Disease

Interventions

DRUG: Stribild (elvitegravir, cobicistat, emtricitabine and tenofovir)

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]